News
If you've been using Zyrtec or Xyzal to combat your allergy symptoms this year, an FDA warning wants you to be aware of this ...
“Reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical ...
13h
Everyday Health on MSNAbruptly Stopping Certain Allergy Drugs Can in Rare Cases Lead to Severe Itching, FDA SaysAbruptly stopping these antihistamines after long-term use without tapering can lead to severe itching, the FDA said.
Japan’s Intellectual Property High Court has ordered Sawai Pharmaceutical (TYO: 4887) and Fuso Pharmaceutical Industries (TYO ...
Rilzabrutinib is a promising treatment option for patients with chronic spontaneous urticaria who are refractory to antihistamines.
Two antihistamines, including Zyrtec, are under warning by the FDA after people reported “severe itching” after ceasing ...
Explore more
Panelists discuss how ruxolitinib provides comprehensive benefits for polycythemia vera patients beyond count control, highlighting its remarkable ability to rapidly alleviate severe pruritus (often ...
The patient’s medical history was significant for mild atopic dermatitis, well-controlled with triamcinolone ointment used ...
1d
News-Medical.Net on MSNEarly allergen introduction reduces childhood food allergy riskInvestigating allergy prevention, this research highlights early intervention strategies and the promise of biologic ...
Early kidney damage often shows subtle signs like foamy urine, swelling, and increased nighttime urination. Fatigue, ...
Earlier this month, the U.S. Food and Drug Administration (FDA) issued a warning regarding two popular allergy medications. Specifically, the agency made clear that stopping long-term use of ...
A new analysis suggests artificial intelligence algorithms are able to accurately assess lesion severity in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results